MedTrace Logo

Project Health: Enhancing Effectiveness of an Obesity Prevention Program

NCT06067763 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2024-11-21

No results posted yet for this study

Summary

This 2-site effectiveness trial will test whether a brief dissonance-based obesity prevention program delivered in single sex groups combined with food response and attention training will produce significantly larger weight gain prevention effects than an educational video control condition. An effectiveness trial is important to test whether this program reduces risk for unhealthy weight gain when delivered by real world clinicians under ecologically valid conditions, which is an important step toward broad implementation. A secondary aim focuses on eating disorder symptom prevention effects. A sample of 17-20 year olds with weight concerns (N = 120) will be randomized to single sex Project Health groups with food response and attention training or an educational video control condition. Participants will complete assessments at baseline, posttest, and 6- and 12-month follow ups.

Conditions

Interventions

BEHAVIORAL

Project Health

A brief dissonance-based obesity prevention program delivered in six one-hour weekly sessions.

BEHAVIORAL

Response and Attention Training

Individualized, computerized response and attention training consisting of five separate tasks designed to increase inhibitory control to reduce overeating.

OTHER

The Weight of the Nation

This 2012 documentary discusses the facts and myths about obesity and the impacts of obesity on individuals and the health care system in the United States.

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER

  • Drexel University

    collaborator OTHER

  • Oregon Research Institute

    lead OTHER

Principal Investigators

  • Eric Stice, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06067763 on ClinicalTrials.gov